Center for Scientific Review; Notice of Closed Meetings, 49114-49115 [2019-20118]
Download as PDF
<![CDATA[
49114
Federal Register / Vol. 84, No. 181 / Wednesday, September 18, 2019 / Notices
Transcripts: Please be advised that as
soon as a transcript of the public
meeting is available, it will be accessible
at https://www.regulations.gov. It may
be viewed at the Dockets Management
Staff (see ADDRESSES). A link to the
transcript will also be available on the
internet at https://www.fda.gov/food/
news-events-cfsan/workshops-meetingswebinars-food-and-dietary-supplements.
Dated: September 12, 2019.
Lowell J. Schiller,
Principal Associate Commissioner for Policy.
[FR Doc. 2019–20229 Filed 9–17–19; 8:45 am]
BILLING CODE 4164–01–P
October 29, 2019, 05:00 p.m., Residence
Inn Bethesda to October 28, 2019, 08:00
a.m. to October 28, 2019, 05:00 p.m.,
Residence Inn Bethesda. The meeting is
closed to the public.
Dated: September 12, 2019.
Ronald J. Livingston, Jr.,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2019–20120 Filed 9–17–19; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Center for Scientific Review; Notice of
Closed Meetings
National Institutes of Health
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Center for Scientific Review; Amended
Notice of Meeting
Notice is hereby given of a change in
the meeting of the Center for Scientific
Review Special Emphasis Panel, ZRG1
DDR–Y 07 October 11, 2019, Cambria
Hotel Rockville, 1 Helen Heneghan
Way, Rockville, MD 20850 which was
published in the Federal Register on
September 10, 2019, 84–FR PG 47528.
The meeting notice is amended to
change the meeting time from 8:00 a.m.–
10:00 a.m. to 11:00 a.m.–1:00 p.m. The
location remains the same. The meeting
is closed to the public.
Dated: September 12, 2019.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2019–20119 Filed 9–17–19; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
khammond on DSKJM1Z7X2PROD with NOTICES
Eunice Kennedy Shriver National
Institute of Child Health & Human
Development; Amended Notice of
Meeting
Notice is hereby given of a change in
the meeting of the National Institute of
Child Health and Human Development
Special Emphasis Panel, Research
Infrastructure for Centers Conducting
Population Dynamics Science FY2019
(P2C), October 28, 2019, 08:00 a.m. to
October 29, 2019, 05:00 p.m., Residence
Inn Bethesda, which was published in
the Federal Register on February 28,
2019, 84 FR 6808.
The date for this meeting has changed
from October 28, 2019, 08:00 a.m. to
VerDate Sep<11>2014
19:01 Sep 17, 2019
Jkt 247001
Name of Committee: Healthcare Delivery
and Methodologies Integrated Review Group;
Community-Level Health Promotion Study
Section.
Date: October 21–22, 2019.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Washington Marriott Georgetown,
1221 22nd Street NW, Washington, DC
20037.
Contact Person: Ping Wu, Ph.D., Scientific
Review Officer, Center for Scientific Review,
National Institutes of Health, 6701 Rockledge
Drive, Room 3166, Bethesda, MD 20892, 301–
451–8428, wup4@csr.nih.gov.
Name of Committee: Interdisciplinary
Molecular Sciences and Training Integrated
Review Group; Cellular and Molecular
Technologies Study Section.
Date: October 22–23, 2019.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: American Inn of Bethesda, 8130
Wisconsin Ave., Bethesda, MD 20814.
Contact Person: Tatiana V. Cohen, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5213,
Bethesda, MD 20892, 301–455–2364,
tatiana.cohen@nih.gov.
Name of Committee: Musculoskeletal, Oral
and Skin Sciences Integrated Review Group;
PO 00000
Frm 00027
Fmt 4703
Sfmt 4703
Arthritis, Connective Tissue and Skin Study
Section.
Date: October 22–23, 2019.
Time: 8:00 a.m. to 5:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: Sheraton BWI (Baltimore), 1100 Old
Elkridge Landing Road, Baltimore, MD
21090.
Contact Person: Robert Gersch, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Bethesda, MD
20817, 301–867–5309, robert.gersch@nih.gov.
Name of Committee: Vascular and
Hematology Integrated Review Group;
Vascular Cell and Molecular Biology Study
Section.
Date: October 22–23, 2019.
Time: 8:00 a.m. to 12:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: The Fairmont Washington, DC, 2401
M Street NW, Washington, DC 20037.
Contact Person: Larry Pinkus, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4132,
MSC 7802, Bethesda, MD 20892, (301) 435–
1214, pinkusl@csr.nih.gov.
Name of Committee: Surgical Sciences,
Biomedical Imaging and Bioengineering
Integrated Review Group; Imaging
Technology Development Study Section.
Date: October 22–23, 2019.
Time: 8:00 a.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Gaithersburg Marriott
Washingtonian Center, 9751 Washingtonian
Center, Gaithersburg, MD 20878.
Contact Person: Yuanna Cheng, MD, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4138,
MSC 7814, Bethesda, MD 20892, (301) 435–
1195, Chengy5@csr.nih.gov.
Name of Committee: Cardiovascular and
Respiratory Sciences Integrated Review
Group; Electrical Signaling, Ion Transport,
and Arrhythmias Study Section.
Date: October 22, 2019.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Canopy by Hilton, 940 Rose Avenue,
North Bethesda, MD 20852.
Contact Person: Sara Ahlgren, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, RM 4136,
Bethesda, MD 20892, 301–435–0904,
sara.ahlgren@nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; PAR Panel:
Predoctoral Training in Advanced Data
Analytics for Behavioral and Social Sciences
Research.
Date: October 22, 2019.
Time: 9:00 a.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
E:\FR\FM\18SEN1.SGM
18SEN1
Federal Register / Vol. 84, No. 181 / Wednesday, September 18, 2019 / Notices
Contact Person: Delia Olufokunbi Sam,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3158,
MSC 7770, Bethesda, MD 20892, 301–435–
0684, olufokunbisamd@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel;
Collaborative Applications: Clinical Studies
of Mental Illness.
Date: October 22, 2019.
Time: 1:00 p.m. to 1:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: Ritz-Carlton Hotel at Pentagon City,
1250 South Hayes Street, Arlington, VA
22202.
Contact Person: Serena Chu, Ph.D.,
Scientific Review Officer, BBBP IRG, Center
for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3178,
MSC 7848, Bethesda, MD 20892, 301–500–
5829, sechu@csr.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: September 12, 2019.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2019–20118 Filed 9–17–19; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Eunice Kennedy Shriver National
Institute of Child Health & Human
Development; Amended Notice of
Meeting
khammond on DSKJM1Z7X2PROD with NOTICES
Notice is hereby given of a change for
the meeting of the Biobehavioral and
Behavioral Sciences Subcommittee,
September 19, 2019, 8:00 a.m. to 6:00
p.m., Residence Inn Bethesda, which
was published in the Federal Register
on June 24, 2019, 84 FR 29529.
The meeting name has been corrected.
The meeting is closed to the public.
Dated: September 12, 2019.
Ronald J. Livingston, Jr.,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2019–20121 Filed 9–17–19; 8:45 am]
BILLING CODE 4140–01–P
VerDate Sep<11>2014
19:01 Sep 17, 2019
Jkt 247001
DEPARTMENT OF HOMELAND
SECURITY
U.S. Customs and Border Protection
Requirement for Certificates of Export
for Importations of Steel Products of
the Republic of Korea
U.S. Customs and Border
Protection, Department of Homeland
Security.
ACTION: General notice.
AGENCY:
This document provides
notice that importations into the United
States of steel products of the Republic
of Korea subject to absolute quota limits
must be presented with valid and
properly executed certificates of
exportation.
DATES: Certificates of exportation for
importations into the United States of
steel products of the Republic of Korea
subject to absolute quota limits are
required for such products entered, or
withdrawn from warehouse, for
consumption on or after October 18,
2019.
FOR FURTHER INFORMATION CONTACT: Julia
Peterson, Quota and Agriculture Branch,
Trade Policy and Programs, (202) 384–
8905, HQQUOTA@cbp.dhs.gov.
SUPPLEMENTARY INFORMATION:
SUMMARY:
Background
Absolute quotas are established by
Presidential proclamations, Executive
orders, and legislative enactments. See
section 132.2(a) of title 19 of the Code
of Federal Regulations (19 CFR
132.2(a)). On April 30, 2018, President
Donald J. Trump signed Proclamation
9740 (83 FR 20683) imposing, among
other things, absolute quota limits on
certain steel products of the Republic of
Korea, pursuant to U.S. Note 16(e),
subchapter III, Chapter 99, Harmonized
Tariff Schedule of the United States
(HTSUS), and subheadings 9903.80.05
through 9903.80.58, HTSUS.
Subsequently, on September 4, 2019,
President Trump signed Proclamation
9777 (83 FR 45025), wherein clause 7
provides that where a government of a
country identified in the superior text to
subheadings 9903.80.05 through
9903.80.58, HTSUS, notifies the United
States that it has established a
mechanism for the certification of
exports to the products covered by the
quantitative limitations applicable to
those subheadings, U.S. Customs and
Border Protection (CBP) may require
that importers of these products furnish
relevant certification of export
information in order to qualify for the
treatment set forth in those subheadings.
If CBP adopts such a requirement,
PO 00000
Frm 00028
Fmt 4703
Sfmt 4703
49115
clause 7 to Proclamation 9777 requires
that CBP shall publish in the Federal
Register notice of the requirement and
procedures for the submission of
relevant certification of export
information. Moreover, clause 7 to
Proclamation 9777 mandates that no
article that is subject to the export
certification requirement announced in
such a notice may be entered for
consumption, or withdrawn from
warehouse for consumption, on or after
the effective date specified in such a
notice, except upon presentation of a
valid and properly executed
certification of export.
The Republic of Korea is a
government of a country identified in
the superior text to subheadings
9903.80.05 through 9903.80.58, HTSUS.
Furthermore, the Republic of Korea has
notified the United States that it has
established a mechanism for the
certification of exports to the products
covered by the quantitative limitations
applicable to these subheadings,
specifically in the form of official
certificates of exportation issued by the
Korea Iron and Steel Association, as
authorized by the Republic of Korea.
This document provides notice that CBP
will require valid and properly executed
certificates of exportation for
importations into the United States of
steel products of the Republic of Korea
covered by the quantitative limitations
applicable to subheadings 9903.80.05
through 9903.80.58, HTSUS, that are
entered, or withdrawn from warehouse,
for consumption on or after October 18,
2019. The subject importations will not
be released unless the entry summaries
are accompanied by valid and properly
executed certificates of exportation, as
described in this notice.
Importers are advised that only
exporters may obtain valid and properly
executed certificates of exportation,
which exporters may apply for online
via the website for the Korea Iron and
Steel Association (https://sq.kosa.or.kr/).
Importers should obtain these
certificates of exportation from
exporters and submit them to CBP with
the entry summaries filed for their
importations. For entries filed through
ACE, additional guidance on the
submission of the certificates of export
is available in a draft portion of the CBP
and Trade Automated Interface
Requirements (CATAIR) for entry
summary filings (specifically, within the
draft chapter designated as the AE
CATAIR), regarding the record entitled
Importer’s Additional Declaration Detail
(https://www.cbp.gov/trade/ace/catair).
E:\FR\FM\18SEN1.SGM
18SEN1
]]>Agencies
[Federal Register Volume 84, Number 181 (Wednesday, September 18, 2019)]
[Notices]
[Pages 49114-49115]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-20118]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: Healthcare Delivery and Methodologies
Integrated Review Group; Community-Level Health Promotion Study
Section.
Date: October 21-22, 2019.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Washington Marriott Georgetown, 1221 22nd Street NW,
Washington, DC 20037.
Contact Person: Ping Wu, Ph.D., Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 3166, Bethesda, MD 20892, 301-451-8428,
[email protected].
Name of Committee: Interdisciplinary Molecular Sciences and
Training Integrated Review Group; Cellular and Molecular
Technologies Study Section.
Date: October 22-23, 2019.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: American Inn of Bethesda, 8130 Wisconsin Ave., Bethesda,
MD 20814.
Contact Person: Tatiana V. Cohen, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5213, Bethesda, MD 20892, 301-
455-2364, [email protected].
Name of Committee: Musculoskeletal, Oral and Skin Sciences
Integrated Review Group; Arthritis, Connective Tissue and Skin Study
Section.
Date: October 22-23, 2019.
Time: 8:00 a.m. to 5:30 p.m.
Agenda: To review and evaluate grant applications.
Place: Sheraton BWI (Baltimore), 1100 Old Elkridge Landing Road,
Baltimore, MD 21090.
Contact Person: Robert Gersch, Ph.D., Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20817, 301-867-5309,
[email protected].
Name of Committee: Vascular and Hematology Integrated Review
Group; Vascular Cell and Molecular Biology Study Section.
Date: October 22-23, 2019.
Time: 8:00 a.m. to 12:00 p.m.
Agenda: To review and evaluate grant applications.
Place: The Fairmont Washington, DC, 2401 M Street NW,
Washington, DC 20037.
Contact Person: Larry Pinkus, Ph.D., Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 4132, MSC 7802, Bethesda, MD 20892, (301) 435-
1214, [email protected].
Name of Committee: Surgical Sciences, Biomedical Imaging and
Bioengineering Integrated Review Group; Imaging Technology
Development Study Section.
Date: October 22-23, 2019.
Time: 8:00 a.m. to 3:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Gaithersburg Marriott Washingtonian Center, 9751
Washingtonian Center, Gaithersburg, MD 20878.
Contact Person: Yuanna Cheng, MD, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4138, MSC 7814, Bethesda, MD
20892, (301) 435-1195, [email protected].
Name of Committee: Cardiovascular and Respiratory Sciences
Integrated Review Group; Electrical Signaling, Ion Transport, and
Arrhythmias Study Section.
Date: October 22, 2019.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Canopy by Hilton, 940 Rose Avenue, North Bethesda, MD
20852.
Contact Person: Sara Ahlgren, Ph.D., Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, RM 4136, Bethesda, MD 20892, 301-435-0904,
[email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; PAR Panel: Predoctoral Training in Advanced Data Analytics
for Behavioral and Social Sciences Research.
Date: October 22, 2019.
Time: 9:00 a.m. to 3:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
[[Page 49115]]
Contact Person: Delia Olufokunbi Sam, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3158, MSC 7770, Bethesda, MD
20892, 301-435-0684, [email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Collaborative Applications: Clinical Studies of Mental
Illness.
Date: October 22, 2019.
Time: 1:00 p.m. to 1:30 p.m.
Agenda: To review and evaluate grant applications.
Place: Ritz-Carlton Hotel at Pentagon City, 1250 South Hayes
Street, Arlington, VA 22202.
Contact Person: Serena Chu, Ph.D., Scientific Review Officer,
BBBP IRG, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3178, MSC 7848, Bethesda, MD
20892, 301-500-5829, [email protected].
(Catalogue of Federal Domestic Assistance Program Nos. 93.306,
Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893,
National Institutes of Health, HHS)
Dated: September 12, 2019.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2019-20118 Filed 9-17-19; 8:45 am]
BILLING CODE 4140-01-P
